Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x100px
Organisation › Details

Biosynth Carbosynth (Group)

Biosynth Carbosynth is a supplier of critical materials to the life science industry with global research, manufacturing and distribution facilities. It is the supplier of choice for many in the pharmaceutical and diagnostic sectors and manufactures and sources a vast range of chemical and biochemical products. The company specializes in carbohydrates, nucleosides, enzyme substrates, peptides, phospholipids, antimicrobials, APIs and natural products and has a full range of reagents for protein production and analysis. Headquartered in Staad, Switzerland, Biosynth Carbosynth is owned by KKR, Ampersand Capital Partners and management. *

 

Period Start 2019-05-20 merged
Period End 2022-09-07 renamed
  Group Biosynth (since 9/22) (Group)
  Today Biosynth (since 9/22) (Group)
  Successor Biosynth (since 9/22) (Group)
Products Industry reagents (bio/biochemical)
  Industry 2 fine chemicals
Person Person Spitz, Urs (Biosynth 201905 CEO)
     
Region Region Switzerland_oo
  Country Switzerland
  Street 4 Rietlistr.
  City 9422 Staad
  Tel +41-71-858-2020
    Address record changed: 2022-09-06
     
Basic data Employees n. a.
     
    * Document for »About Section«: Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad.
     
   
Record changed: 2024-12-29

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Biosynth (since 9/22) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x300px




» top